Navigation Links
New Kit Takes the Uncertainty Out of Lymphoma Diagnosis
Date:11/9/2011

ALBUQUERQUE, New Mexico, November 9, 2011 /PRNewswire/ --

A new diagnostic kit which takes the uncertainty out of lymphoma diagnosis, has been launched at the Veterinary Cancer Society's annual conference this month.

Developed by PetScreen (http://www.pet-screen.com) in the UK, the announcement is a significant breakthrough in the diagnosis of canine lymphoma with the major benefit being that it is able to differentiate between patients with lymphadenopathy due to lymphoma and lymphadenopathy due to other ailments such as lymphoid hyperplasia.  

The announcement also signals a partnership and commercial venture between PetScreen Ltd and Tridelta Development Ltd to jointly develop manufacture and market a unique range of veterinary cancer diagnostic kits under the banner of 'Tri-Screen' (http://www.tri-screen.net). PetScreen has established the first reference laboratory offering the Advanced Lymphoma Blood Test (ALBT) utilising the Tri-Screen Canine Lymphoma assay kit.  The kit is available now to enable laboratories worldwide to offer veterinarians this advanced testing system.

For the past two years, PetScreen's research team have been busy characterising and identifying the biomarkers used in their earlier lymphoma blood test.  They found that two of the markers are Acute Phase Proteins (APP's).  Although APP's have been investigated in veterinary medicine for some time PetScreen has developed a unique multi-marker approach which led to the development of patented and copyrighted analytical algorithms which combine the relative values of both Haptoglobin and C-Reactive Protein (CRP) in serum.  

By enlisting the support of vets in the UK and USA the assay has been rigorously tested with 194 canine patients with lymphoma, benign lymphoid hyperplasia and other diseases with similar presentation to lymphoma as well as healthy dogs.

By testing the acute phase proteins using immunoassay, PetScreen achieved excellent levels of high performance, reproducibility and objectivity. The combination of the three diagnostic elements enables differentiation with a very high degree of sensitivity and specificity … ensuring an appropriate treatment regimen can begin at a critical early stage of disease identification and development.

In order to make this available to a global reference laboratory market, a partner with a unique understanding of APP diagnostic kit manufacture and marketing was required … it quickly became apparent that Tridelta's reputation and experience with the international pharmaceutical industry in this niche sector qualified their preferred partner status.  Each company brings its own strengths to the Tri-Screen brand of diagnostic kits.  For Tridelta it is an important step into the companion animal marketplace; for PetScreen, the opportunity to globalise and advance their veterinary diagnostics expertise in this important and rapidly emerging sector.

For further information please contact:  
Graeme.radcliffe@btconnect.com
brianh@trideltaltd.com


'/>"/>
SOURCE PetScreen
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Graphenes quantum leap takes electronics a step closer
2. Cord Blood America Announces Reverse Stock Split Takes Effect Monday, May 9, 2011
3. CPTA Takes a Step Toward Improving Patient Access to Physical Therapy Services
4. Computer memory takes a spin
5. Terso Solutions RFID Jump Start Takes the Risk Out of Implementing RFID for Hospitals and Research Laboratories Looking to Streamline Operations and Improve Regulatory Compliance
6. Founder and ex-CEO of eSolar Asif Ansari takes the helm of Canadian startup Morgan Solar
7. Prototype Software from Elektas Research Group Takes First Place in Two Autosegmentation Contests at MICCAI 2010
8. Case Western Reserve University-led team takes high resolution photo of a K+ channel
9. New test takes guesswork out of diagnosing early stage Alzheimers disease
10. BioSpec Global Solutions Inc, takes delivery of new TOGs 3000 Home edition for the U.S. and international markets
11. Medizone International Takes Aim at the Bioterrorism Countermeasures Arena
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces expanded coverage of ... newest module, US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats and ... synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates the market ...
(Date:10/12/2017)... CA (PRWEB) , ... October ... ... (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed ... bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who made ...
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... CA, USA (PRWEB) , ... October 11, 2017 , ... ... to take place on 7th and 8th June 2018 in San Francisco, CA. The ... influencers as well as several distinguished CEOs, board directors and government officials from around ...
Breaking Biology Technology:
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
(Date:4/5/2017)... YORK , April 5, 2017 Today ... is announcing that the server component of the HYPR ... known for providing the end-to-end security architecture that empowers ... HYPR has already secured over 15 million ... makers including manufacturers of connected home product suites and ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
Breaking Biology News(10 mins):